Literature DB >> 32960853

Early adolescent subchronic low-dose nicotine exposure increases subsequent cocaine and fentanyl self-administration in Sprague-Dawley rats.

Anjelica Cardenas1, Maricela Martinez2, Alejandra Saenz Mejia3, Shahrdad Lotfipour1,4.   

Abstract

An exponential rise in nicotine-containing electronic-cigarette use has been observed during the period of adolescence. Preclinical studies have shown that nicotine exposure during early adolescence, but not adulthood, increases subsequent drug intake and reward. Although growing clinical trends highlight that stimulant use disorders are associated with the opioid epidemic, very few studies have assessed the effects of adolescent nicotine exposure on opioid intake. The objective of our current study is to develop a new animal model to assess the causal relationship of adolescent nicotine exposure on subsequent opioid intake. In this effort, we first replicate previous studies using a well-established 4-day nicotine paradigm. Rats are pretreated with a low dose of nicotine (2 × , 30 μg/kg/0.1 mL, intravenous) or saline during early adolescence (postnatal days 28-31) or adulthood (postnatal days 86-89). Following nicotine pretreatment on postnatal day 32 or postnatal day 90, animals underwent operant intravenous self-administration for the psychostimulant, cocaine [500 μg/kg/infusion (inf)] or the opioid, fentanyl (2.5 μg/kg/inf). We successfully show that adolescent but not adult, nicotine exposure enhances cocaine self-administration in male rats. Furthermore, we illustrate early adolescent but not adult nicotine exposure enhances fentanyl self-administration, independent of sex. Overall, our findings highlight that adolescence is a unique period of development that is vulnerable to nicotine-induced enhancement for cocaine and fentanyl self-administration in rats.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32960853      PMCID: PMC7790845          DOI: 10.1097/FBP.0000000000000593

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.277


  43 in total

1.  Extent of smoking and nicotine dependence in the United States: 1991-1993.

Authors:  D B Kandel; K Chen
Journal:  Nicotine Tob Res       Date:  2000-08       Impact factor: 4.244

2.  Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.

Authors:  R Andrew Chambers; David W Self
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

Review 3.  Adolescent development of forebrain stimulant responsiveness: insights from animal studies.

Authors:  Frances M Leslie; Sandra E Loughlin; Ruihua Wang; Lilyanna Perez; Shahrdad Lotfipour; James D Belluzzia
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

Review 4.  Molecular and cellular aspects of nicotine abuse.

Authors:  J A Dani; S Heinemann
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

Review 5.  Interactions between nicotine and drugs of abuse: a review of preclinical findings.

Authors:  Stephen J Kohut
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-02       Impact factor: 3.829

6.  Nicotine alters limbic function in adolescent rat by a 5-HT1A receptor mechanism.

Authors:  Jasmin M Dao; Susan C McQuown; Sandra E Loughlin; James D Belluzzi; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2011-03-16       Impact factor: 7.853

Review 7.  Opiate versus psychostimulant addiction: the differences do matter.

Authors:  Aldo Badiani; David Belin; David Epstein; Donna Calu; Yavin Shaham
Journal:  Nat Rev Neurosci       Date:  2011-10-05       Impact factor: 34.870

8.  Acetaldehyde enhances acquisition of nicotine self-administration in adolescent rats.

Authors:  James D Belluzzi; Ruihua Wang; Frances M Leslie
Journal:  Neuropsychopharmacology       Date:  2005-04       Impact factor: 7.853

Review 9.  Reward processing by the opioid system in the brain.

Authors:  Julie Le Merrer; Jérôme A J Becker; Katia Befort; Brigitte L Kieffer
Journal:  Physiol Rev       Date:  2009-10       Impact factor: 37.312

Review 10.  Guidelines on nicotine dose selection for in vivo research.

Authors:  Shannon G Matta; David J Balfour; Neal L Benowitz; R Thomas Boyd; Jerry J Buccafusco; Anthony R Caggiula; Caroline R Craig; Allan C Collins; M Imad Damaj; Eric C Donny; Phillip S Gardiner; Sharon R Grady; Ulrike Heberlein; Sherry S Leonard; Edward D Levin; Ronald J Lukas; Athina Markou; Michael J Marks; Sarah E McCallum; Neeraja Parameswaran; Kenneth A Perkins; Marina R Picciotto; Maryka Quik; Jed E Rose; Adrian Rothenfluh; William R Schafer; Ian P Stolerman; Rachel F Tyndale; Jeanne M Wehner; Jeffrey M Zirger
Journal:  Psychopharmacology (Berl)       Date:  2006-08-09       Impact factor: 4.530

View more
  3 in total

Review 1.  Unique effects of nicotine across the lifespan.

Authors:  Michelle Ren; Shahrdad Lotfipour; Frances Leslie
Journal:  Pharmacol Biochem Behav       Date:  2022-02-03       Impact factor: 3.533

2.  Adolescent nicotine treatment causes robust locomotor sensitization during adolescence but impedes the spontaneous acquisition of nicotine intake in adult female Wistar rats.

Authors:  Ranjithkumar Chellian; Azin Behnood-Rod; Ryann Wilson; Marcelo Febo; Adriaan W Bruijnzeel
Journal:  Pharmacol Biochem Behav       Date:  2021-06-28       Impact factor: 3.697

3.  Sex- and Genotype-Dependent Nicotine-Induced Behaviors in Adolescent Rats with a Human Polymorphism (rs2304297) in the 3'-UTR of the CHRNA6 Gene.

Authors:  Anjelica Cardenas; Yu Bai; Yasamin Hajy Heydary; Jiaqi Li; Frances M Leslie; Shahrdad Lotfipour
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.